Korean Circ J.  2015 Jul;45(4):259-265. 10.4070/kcj.2015.45.4.259.

Roles of Intravascular Ultrasound in Patients with Acute Myocardial Infarction

Affiliations
  • 1Division of Cardiology of Chonnam National University Hospital, Heart Convergence Research Center Nominated by Korea Ministry of Health and Welfare, Gwangju, Korea. myungho@chollian.net

Abstract

Rupture of a vulnerable plaque and subsequent thrombus formation are important mechanisms leading to the development of an acute myocardial infarction (AMI). Typical intravascular ultrasound (IVUS) features of AMI include plaque rupture, thrombus, positive remodeling, attenuated plaque, spotty calcification, and thin-cap fibroatheroma. No-reflow phenomenon was attributable to the embolization of thrombus and plaque debris that results from mechanical fragmentation of the vulnerable plaque by percutaneous coronary intervention (PCI). Several grayscale IVUS features including plaque rupture, thrombus, positive remodeling, greater plaque burden, decreased post-PCI plaque volume, and tissue prolapse, and virtual histology-IVUS features such as large necrotic corecontaining lesion and thin-cap fibroatheroma were the independent predictors of no-reflow phenomenon in AMI patients. Non-culprit lesions associated with recurrent events were more likely than those not associated with recurrent events to be characterized by a plaque burden of > or =70%, a minimal luminal area of < or =4.0 mm2, or to be classified as thin-cap fibroatheromas.

Keyword

Myocardial infarction; Atherosclerosis; Ultrasonography, interventional

MeSH Terms

Atherosclerosis
Humans
Myocardial Infarction*
No-Reflow Phenomenon
Percutaneous Coronary Intervention
Phenobarbital
Plaque, Atherosclerotic
Prolapse
Rupture
Thrombosis
Ultrasonography*
Ultrasonography, Interventional
Phenobarbital

Figure

  • Fig. 1 Intravascular ultrasound findings in patients with acute myocardial infarction. (A) Plaque rupture with a cavity that communicated with the lumen with an overlying residual fibrous cap fragment, (B) intracoronary thrombus shows a distinct hypoechoic mass, (C) positive remodeling with a remodeling index of 1.21, (D) attenuated plaque shows hypoechoic plaque with deep ultrasound attenuation without calcification or very dense fibrous plaque, (E) thin-cap fibroatheroma with a necrotic core of 35.4% of plaque area in the presence of 83.3% of plaque burden, and (F) tissue prolapse shows an intraluminal tissue extrusion through the stent struts.


Cited by  1 articles

Successful Treatment of Coronary Spasm with Atherosclerosis Rapidly Progressing to Acute Myocardial Infarction in a Young Woman
Xiongyi Han, Myung Ho Jeong, Doo Sun Sim, Min Chul Kim, Yongcheol Kim, Ju Han Kim, Young Joon Hong, Youngkeun Ahn
J Lipid Atheroscler. 2018;7(1):68-75.    doi: 10.12997/jla.2018.7.1.68.


Reference

1. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984; 310:1137–1140.
2. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996; 93:1354–1363.
3. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001; 37:1478–1492.
4. Iijima R, Shinji H, Ikeda N, et al. Comparison of coronary arterial finding by intravascular ultrasound in patients with "transient no-reflow" versus "reflow" during percutaneous coronary intervention in acute coronary syndrome. Am J Cardiol. 2006; 97:29–33.
5. Katayama T, Kubo N, Takagi Y, et al. Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol. 2006; 97:301–304.
6. Tanaka A, Kawarabayashi T, Nishibori Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation. 2002; 105:2148–2152.
7. Kotani J, Mintz GS, Castagna MT, et al. Usefulness of preprocedural coronary lesion morphology as assessed by intravascular ultrasound in predicting Thrombolysis In Myocardial Infarction frame count after percutaneous coronary intervention in patients with Q-wave acute myocardial infarction. Am J Cardiol. 2003; 91:870–872.
8. Sato H, Iida H, Tanaka A, et al. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. J Am Coll Cardiol. 2004; 44:300–304.
9. Hong YJ, Jeong MH, Choi YH, et al. Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis. Eur Heart J. 2011; 32:2059–2066.
10. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364:226–235.
11. Kim WH, Park HW, Kim KH, et al. Fibro-fatty component is important for the long-term clinical events in patients who have undergone primary percutaneous coronary intervention. Korean Circ J. 2012; 42:33–39.
12. Kim KH, Kim WH, Park HW, et al. Impact of plaque composition on long-term clinical outcomes in patients with coronary artery occlusive disease. Korean Circ J. 2013; 43:377–383.
13. Singh V, Badheka AO, Arora S, et al. Comparison of inhospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus angiography. Am J Cardiol. 2015; 115:1357–1366.
14. Maehara A, Mintz GS, Bui AB, et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol. 2002; 40:904–910.
15. Hong YJ, Jeong MH, Choi YH, et al. Differences in intravascular ultrasound findings in culprit lesions in infarct-related arteries between ST segment elevation myocardial infarction and non-ST segment elevation myocardial infarction. J Cardiol. 2010; 56:15–22.
16. Kusama I, Hibi K, Kosuge M, et al. Impact of plaque rupture on infarct size in ST-segment elevation anterior acute myocardial infarction. J Am Coll Cardiol. 2007; 50:1230–1237.
17. Fujii K, Kobayashi Y, Mintz GS, et al. Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation. 2003; 108:2473–2478.
18. Nakamura M, Nishikawa H, Mukai S, et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 2001; 37:63–69.
19. Hasegawa T, Ehara S, Kobayashi Y, et al. Acute myocardial infarction: clinical characteristics and plaque morphology between expansive remodeling and constrictive remodeling by intravascular ultrasound. Am Heart J. 2006; 151:332–337.
20. Endo M, Hibi K, Shimizu T, et al. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010; 3:540–549.
21. Wu X, Mintz GS, Xu K, et al. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv. 2011; 4:495–502.
22. Lee SY, Mintz GS, Kim SY, et al. Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2009; 2:65–72.
23. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000; 20:1262–1275.
24. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995; 91:2844–2850.
25. Rodriguez-Granillo GA, García-García HM, Mc Fadden EP, et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol. 2005; 46:2038–2042.
26. Hong MK, Mintz GS, Lee CW, et al. Comparison of virtual histology to intravascular ultrasound of culprit coronary lesions in acute coronary syndrome and target coronary lesions in stable angina pectoris. Am J Cardiol. 2007; 100:953–959.
27. Peterson ED, Jollis JG, Bebchuk JD, et al. Changes in mortality after myocardial revascularization in the elderly. The national Medicare experience. Ann Intern Med. 1994; 121:919–927.
28. De Gregorio J, Kobayashi Y, Albiero R, et al. Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. J Am Coll Cardiol. 1998; 32:577–583.
29. Hassani SE, Mintz GS, Fong HS, et al. Negative remodeling and calcified plaque in octogenarians with acute myocardial infarction: an intravascular ultrasound analysis. J Am Coll Cardiol. 2006; 47:2413–2419.
30. Sano T, Tanaka A, Namba M, et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation. 2003; 108:282–285.
31. Tanaka A, Shimada K, Sano T, et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol. 2005; 45:1594–1599.
32. Bocksch W, Schartl M, Beckmann S, Dreysse S, Fleck E. Intravascular ultrasound imaging in patients with acute myocardial infarction. Eur Heart J. 1995; 16:Suppl J. 46–52.
33. Hong MK, Park SW, Lee CW, et al. Long-term outcomes of minor plaque prolapsed within stents documented with intravascular ultrasound. Catheter Cardiovasc Interv. 2000; 51:22–26.
34. Hong YJ, Jeong MH, Ahn Y, et al. Plaque prolapse after stent implantation in patients with acute myocardial infarction: an intravascular ultrasound analysis. JACC Cardiovasc Imaging. 2008; 1:489–497.
35. van der Hoeven BL, Liem SS, Dijkstra J, et al. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study. JACC Cardiovasc Interv. 2008; 1:192–201.
36. Kusama I, Hibi K, Kosuge M, et al. Impact of plaque rupture on infarct size in ST-segment elevation anterior acute myocardial infarction. J Am Coll Cardiol. 2007; 50:1230–1237.
37. Hong YJ, Jeong MH, Choi YH, et al. Positive remodeling is associated with more plaque vulnerability and higher frequency of plaque prolapse accompanied with post-procedural cardiac enzyme elevation compared with intermediate/negative remodeling in patients with acute myocardial infarction. J Cardiol. 2009; 53:278–287.
38. Hong YJ, Jeong MH, Choi YH, et al. Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction. J Cardiol. 2009; 54:36–44.
39. Ohshima K, Ikeda S, Kadota H, et al. Cavity volume of ruptured plaque is an independent predictor for angiographic no-reflow phenomenon during primary angioplasty in patients with ST-segment elevation myocardial infarction. J Cardiol. 2011; 57:36–43.
40. Kawaguchi R, Oshima S, Jingu M, et al. Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007; 50:1641–1646.
41. Kawamoto T, Okura H, Koyama Y, et al. The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol. 2007; 50:1635–1640.
42. Bae JH, Kwon TG, Hyun DW, Rihal CS, Lerman A. Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study. Heart. 2008; 94:1559–1564.
43. Nakamura T, Kubo N, Ako J, Momomura S. Angiographic no-reflow phenomenon and plaque characteristics by virtual histology intravascular ultrasound in patients with acute myocardial infarction. J Interv Cardiol. 2007; 20:335–339.
44. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007; 369:667–678.
45. van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry. J Am Coll Cardiol. 2009; 53:1399–1409.
46. Kimura T, Morimoto T, Nakagawa Y, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009; 119:987–995.
47. Choi SY, Witzenbichler B, Maehara A, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy. Circ Cardiovasc Interv. 2011; 4:239–247.
48. Hong YJ, Jeong MH, Choi YH, et al. Clinical, angiographic, and intravascular ultrasound predictors of early stent thrombosis in patients with acute myocardial infarction. Int J Cardiol. 2013; 168:1674–1675.
49. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL-cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005; 352:29–38.
50. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006; 295:1556–1565.
51. Lehman SJ, Schlett CL, Bamberg F, et al. Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score. JACC Cardiovasc Imaging. 2009; 2:1262–1270.
52. Nicholls SJ, Tuzcu EM, Wolski K, et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol. 2007; 49:263–270.
53. Hong YJ, Jeong MH, Choi YH, et al. Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day. Am J Cardiol. 2010; 106:1241–1247.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr